{
  "url": "https://struct.news/briefs/haemonetics-operating-cash-flow-tripled-as-net-income-slipped",
  "title": "Haemonetics' operating cash flow tripled as net income slipped",
  "summary": "Operating cash flow reached $52.3 million in the three months ended June 27, up 201% from a year earlier.",
  "published_at": "2026-08-06T10:13:09.796378+00:00",
  "publisher": "Struct",
  "usage": "Figures are as reported by the company. Quote with attribution to the source filing.",
  "company": {
    "name": "Haemonetics Corporation",
    "ticker": "HAE",
    "cik": "313143",
    "sector": "Healthcare",
    "industry": "Medical Devices"
  },
  "source_filing": {
    "form": "10-Q",
    "filed": "2026-08-06",
    "accession": "0000313143-26-000120",
    "url": "https://www.sec.gov/Archives/edgar/data/313143/000031314326000120/hae-20260627.htm"
  },
  "comparison_filing": {
    "form": "10-Q",
    "filed": "2025-08-07",
    "url": "https://www.sec.gov/Archives/edgar/data/313143/000031314325000058/hae-20250628.htm"
  },
  "reported_figures": [
    {
      "group": "The filing in three numbers",
      "label": "Revenue",
      "value": 1334027000,
      "display": "$1.3B",
      "unit": "usd",
      "period": "2026-03-28",
      "detail": null,
      "source": {
        "kind": "sec_filing",
        "label": "Filed company results",
        "form": "10-Q",
        "accession": "0000313143-26-000120",
        "filing_date": "2026-08-06"
      }
    },
    {
      "group": "The filing in three numbers",
      "label": "Revenue YoY",
      "value": -1.9691745589436982,
      "display": "-2.0%",
      "unit": "percent",
      "period": "2026-03-28",
      "detail": null,
      "source": {
        "kind": "jodie_calculation",
        "label": "Calculated from filed company results",
        "form": "10-Q",
        "accession": "0000313143-26-000120",
        "filing_date": "2026-08-06"
      }
    },
    {
      "group": "The filing in three numbers",
      "label": "Operating margin",
      "value": 11.748937615205689,
      "display": "+11.7%",
      "unit": "percent",
      "period": "2026-03-28",
      "detail": null,
      "source": {
        "kind": "jodie_calculation",
        "label": "Calculated from filed company results",
        "form": "10-Q",
        "accession": "0000313143-26-000120",
        "filing_date": "2026-08-06"
      }
    }
  ],
  "watch_next": [
    {
      "type": "interest_rates",
      "statement": "The latest period links higher interest expense to borrowing under the revolving credit facility, adding a current financing exposure below operating income.",
      "importance": "medium",
      "evidence": "The increase was primarily due to increase interest expense resulting from the borrowing of the revolving credit facility, partially offset by additional gains recognized on the previously held equity interest in Vivasure Medical Limited (“Vivasure”).",
      "source_date": "2026-08-06"
    }
  ],
  "related_tickers": [
    "HAE"
  ],
  "disclaimer": "Descriptive reporting of filed results. Not investment advice, and contains no forecast or recommendation."
}